Kestra Investment Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1962449
AUSTIN, TX
Position in ALNY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$788,096
-$1,989,888 QoQ
Shares Held
2,618
-68.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#431
of 784 holders
Holding Since
Dec 2024
4 quarters on record
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Investment Management, LLC holds $5,070,571 across 6 Biotechnology names. ALNY ranks #3 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
31,530 | $1,715,547 | |
| 2 | INCY |
Incyte Corp
|
12,148 | $1,377,097 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,618 | $788,096 | |
| 4 | RPRX |
Royalty Pharma plc
|
7,788 | $436,673 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
659 | $410,912 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
689 | $342,246 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $788,096 | 2,618 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,777,984 | 8,396 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,391,467 | 6,014 | Shares | Sole | 2026-02-09 | |
| 2024-12-31 | $705 | 3 | Shares | Sole | 2025-01-31 | |
| No filing history on record for this holder in this stock. | ||||||